Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Idaho, your point
the time factor is really referring to the pharmacokinetics of the the drug, not a time factor of convenience for the patient. The million dollar question is: Will there be a decrease in the long term progression of diabetic complications with a combination drug-
was going to be my exact response. This is the holy grail of diabetes research, i.e., mimicking the body's normal response to a carbohydrate load. The fact that we have not yet met that challenge is the reason why so many diabetics suffer devastating complications and shortened life spans. Dr. Lim never fails to overtly state that the "quicker response" is for the purpose of mimicking the body's natural mechanisms.
Good luck!
-Fritz